Jacob T. Martin

1.7k total citations
23 papers, 907 citations indexed

About

Jacob T. Martin is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jacob T. Martin has authored 23 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Jacob T. Martin's work include Hepatitis B Virus Studies (10 papers), Hepatitis Viruses Studies and Epidemiology (8 papers) and Immunotherapy and Immune Responses (5 papers). Jacob T. Martin is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis Viruses Studies and Epidemiology (8 papers) and Immunotherapy and Immune Responses (5 papers). Jacob T. Martin collaborates with scholars based in United States, Canada and Germany. Jacob T. Martin's co-authors include Ravi S. Kane, William L. Heyward, Dhananjoy Mondal, Robert S. Janssen, Darrell J. Irvine, Sean Bennett, Hamid Namini, Indrani Banerjee, Michael R. Powell and Ceon Ramon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Biomaterials.

In The Last Decade

Jacob T. Martin

23 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob T. Martin United States	16	296	289	223	208	126	23	907
Rouhollah Vahabpour Iran	19	293 1.0×	226 0.8×	85 0.4×	105 0.5×	43 0.3×	65	759
María J. Gómara Spain	22	554 1.9×	249 0.9×	192 0.9×	166 0.8×	73 0.6×	81	1.3k
Weimin Nie China	14	188 0.6×	147 0.5×	117 0.5×	88 0.4×	224 1.8×	24	726
Eugenio Hardy Cuba	20	682 2.3×	148 0.5×	141 0.6×	29 0.1×	96 0.8×	61	1.1k
Shetha Shukair United States	10	359 1.2×	193 0.7×	432 1.9×	16 0.1×	30 0.2×	14	1.1k
Zhongchao Zhao United States	15	230 0.8×	115 0.4×	129 0.6×	56 0.3×	63 0.5×	35	674
Yongge Wu China	19	1.1k 3.7×	274 0.9×	181 0.8×	41 0.2×	51 0.4×	59	1.7k
Veronica D. Gonzalez Argentina	19	413 1.4×	200 0.7×	841 3.8×	80 0.4×	87 0.7×	50	1.5k
Osamu Moriya Japan	19	237 0.8×	121 0.4×	296 1.3×	69 0.3×	33 0.3×	106	1.3k
Frederico Aires‐da‐Silva Portugal	18	543 1.8×	103 0.4×	197 0.9×	17 0.1×	93 0.7×	41	1.1k

Countries citing papers authored by Jacob T. Martin

Since Specialization

Citations

This map shows the geographic impact of Jacob T. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob T. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob T. Martin more than expected).

Fields of papers citing papers by Jacob T. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob T. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob T. Martin. The network helps show where Jacob T. Martin may publish in the future.

Co-authorship network of co-authors of Jacob T. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob T. Martin. A scholar is included among the top collaborators of Jacob T. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob T. Martin. Jacob T. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Jacob T., Brittany L. Hartwell, Mariane B. Melo, et al.. (2021). Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates. Biomaterials. 275. 120868–120868. 24 indexed citations

Tahir, Mukarram, Laura R. Arriaga, Yu-Sang Sabrina Yang, et al.. (2020). Calcium-triggered fusion of lipid membranes is enabled by amphiphilic nanoparticles. Proceedings of the National Academy of Sciences. 117(31). 18470–18476. 47 indexed citations

Martin, Jacob T., et al.. (2018). Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency. International Journal of Nanomedicine. Volume 13. 5249–5253. 5 indexed citations

Bera, Smritilekha, Dhananjoy Mondal, Jacob T. Martin, & Man Singh. (2015). Potential effect of ultrasound on carbohydrates. Carbohydrate Research. 410. 15–35. 26 indexed citations

Heyward, William L., et al.. (2015). Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus. Vaccine. 33(7). 833–837. 29 indexed citations

Boggara, Mohan, Ronak Maheshwari, Manish Arha, et al.. (2014). Design of Monodisperse and Well‐Defined Polypeptide‐Based Polyvalent Inhibitors of Anthrax Toxin. Angewandte Chemie International Edition. 53(31). 8037–8040. 15 indexed citations

Heyward, William L., Matthew Davis, Keith S. Reisinger, et al.. (2013). Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age. Vaccine. 31(46). 5300–5305. 91 indexed citations

Halperin, Scott A., Brian J. Ward, Marc Dionne, et al.. (2013). Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine. Human Vaccines & Immunotherapeutics. 9(7). 1438–1444. 23 indexed citations

Janssen, Robert S., Roberto Mangoo‐Karim, Pablo E. Pérgola, et al.. (2013). Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease. Vaccine. 31(46). 5306–5313. 61 indexed citations

10.

Janssen, Robert S., Sean Bennett, Hamid Namini, William L. Heyward, & Jacob T. Martin. (2013). 1426 IMMUNOGENICITY AND SAFETY OF TWO DOSES OF INVESTIGATIONAL HEPLISAV™ COMPARED TO THREE DOSES OF LICENSED HEPATITIS B VACCINE (ENGERIX-B®) IN TWO PHASE 3 TRIALS. Journal of Hepatology. 58. S574–S574. 2 indexed citations

11.

Halperin, Scott A., Shelly McNeil, Joanne M. Langley, et al.. (2012). Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults. Vaccine. 30(36). 5445–5448. 26 indexed citations

12.

Halperin, Scott A., Brian J. Ward, Curtis Cooper, et al.. (2012). Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age. Vaccine. 30(15). 2556–2563. 106 indexed citations

13.

Joshi, Amit, Vincent Kwok‐Man Poon, Dhananjoy Mondal, et al.. (2011). Structure-Based Design of a Heptavalent Anthrax Toxin Inhibitor. Biomacromolecules. 12(3). 791–796. 33 indexed citations

14.

Banerjee, Indrani, Dhananjoy Mondal, Jacob T. Martin, & Ravi S. Kane. (2010). Photoactivated Antimicrobial Activity of Carbon Nanotube−Porphyrin Conjugates. Langmuir. 26(22). 17369–17374. 58 indexed citations

15.

McNeil, Shelly, Scott A. Halperin, Randy Hart, et al.. (2010). 77: Safety and Immunogenicity of a Novel Hepatitis B Vaccine Adjuvanted With Immunostimulatory Sequence (ISS) in Renal Predialysis and Dialyis Patients. American Journal of Kidney Diseases. 55(4). B51–B51. 2 indexed citations

16.

Vance, David J., et al.. (2009). The design of polyvalent scaffolds for targeted delivery☆. Advanced Drug Delivery Reviews. 61(11). 931–939. 35 indexed citations

17.

Zhou, Jing, Boonchoy Soontornworajit, Jacob T. Martin, et al.. (2009). A Hybrid DNA Aptamer–Dendrimer Nanomaterial for Targeted Cell Labeling. Macromolecular Bioscience. 9(9). 831–835. 50 indexed citations

18.

Martin, Jacob T., et al.. (2009). 1040 A PHASE 3 SAFETY AND EFFICACY STUDY COMPARING IMMUNOGENICITY OF TWO DOSES OF HBsAg COMBINED WITH IMMUNOSTIMULATORY SEQUENCE WITH THREE DOSES OF LICENSED HEPATITIS VACCINE. Journal of Hepatology. 50. S377–S377. 1 indexed citations

19.

Greenspoon, Jeffrey S., et al.. (1989). Necessity for routine obstetric screening for hepatitis B surface antigen.. PubMed. 34(9). 655–8. 6 indexed citations

20.

Ramon, Ceon, Jacob T. Martin, & Michael R. Powell. (1987). Low‐level, magnetic‐field‐induced growth modification of Bacillus subtilis. Bioelectromagnetics. 8(3). 275–282. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact